FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to novel derivatives of quinoline of the general formula (I) where R means unsubstituted C1-C3-alkyl or C2-C3-alkenyl; R1 is cyano-group that are agonists of alpha-2-adrenoreceptors and can be used for preparing drugs that are useful for treatment of patients with nose congestion, glaucoma, diarrhea, asthma. Compounds show the expressed antagonistic activity with respect to α-2-adrenoreceptors. EFFECT: new compounds indicated above, enhanced effectiveness in treatment. 9 cl, 1 tbl, 3 ex
Authors
Dates
2001-01-20—Published
1994-12-15—Filed